XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
20.33
-0.64 (-3.05%)
Mar 28, 2025, 4:00 PM EDT - Market closed
XOMA Royalty Employees
XOMA Royalty had 13 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$2,191,308
Profits / Employee
-$1,484,077
Market Cap
243.53M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
XOMA News
- 9 days ago - XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewsWire
- 11 days ago - XOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business Achievements - GlobeNewsWire
- 4 weeks ago - Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences - GlobeNewsWire
- 4 weeks ago - XOMA Royalty to Present at Investor Conferences in March - GlobeNewsWire
- 7 weeks ago - XOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 5 months ago - XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities - GlobeNewsWire
- 5 months ago - XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience - GlobeNewsWire
- 5 months ago - Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash - Business Wire